Evaluating Targeted Therapeutic Options in Relapsed/Refractory Follicular Lymphoma

Evaluating Targeted Therapeutic Options in Relapsed/Refractory Follicular Lymphoma

Utilize appropriate tools to identify and assess R/R FL Evaluate the mechanisms of action, most recent safety and efficacy data, and clinical considerations associated with novel targeted therapies and combinations in R/R FL Implement multidisciplinary team strategies and shared decision-making to select optimal treatment and support patients with R/R FL

  • Provider:HMP Education
  • Activity Link: https://www.hmpeducation.com/program/2024-gduhem-103
  • Start Date: 2024-08-29 05:00:00
  • End Date: 2024-08-29 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: Source: Ipsen - Amount: 0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: General Surgery
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.